The Middle East as an important region for HUMAN’s international business
HUMAN is one of the global players in the in-vitro diagnostics industry. With its broad network of subsidiaries and long-standing distribution partners, the German medium-sized company with its headquarters in Wiesbaden (near Frankfurt) supports medical laboratories in more than 160 countries. For its customers of the Arab world, HUMAN also maintains a regional office in Sharjah, UAE.
Middle East and North Africa (MENA) is an important region for HUMAN’s international business. The major driving factor linked to the growth of the IVD industry in this region is the high burden of chronic diseases, especially infectious diseases, cancer, and diabetes. The UAE, for instance, has one of the world’s highest rates of diabetes, at about 18.7 percent, which is a huge medical, but also an economic burden.
With its Diabetes Dx products, HUMAN helps to ease and improve both an early diagnosis of diabetes, but also better diabetes monitoring and diabetes management. Regardless of whether this is to be done at the point of care or if the blood analysis is done in a specialized laboratory – HUMAN’s Diabetes Dx products fulfill every need with highest quality and precision in combination with rapid results and easy handling.
Reveal undiagnosed diabetics by WHO-recommended HbA1c testing
One of HUMAN‘s featured products at Medlab 2023 was HumaNex A1c Variant, an HPLC system for small and medium-scale measurement of glycated hemoglobin HbA1c. Since 2009, the World Health Organization (WHO) has recommended HbA1c as a reliable test for the diagnosis of diabetes, ensuring early intervention strategies.
